S&P ASX All Technology

US Dollar vs AUD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

ORTX Orchard Therapeutics PLC

16.70

0.00 (0.00%)

03 May 2024 - Closed

Delayed by 15 minutes

Orchard expands Be The Match Bio collaboration ahead of Libmeldy launch

To read the full story on Seeking Alpha, click here.

Orchard Therapeutics (NASDAQ:ORTX)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Orchard Therapeutics Charts.

Orchard Therapeutics (NASDAQ:ORTX)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Orchard Therapeutics Charts.

Orchard Therapeutics PLC News

Orchard Therapeutics Co-founder and Chief Executive Officer Dr. Bobby Gaspar Named to Inaugural 2024 TIME100 Health List
Friday 3 May 2024 (23 hours ago) • GlobeNewswire Inc.

Orchard Therapeutics Outlines U.S. Launch Plans for Lenmeldy™ (atidarsagene autotemcel), the Only Approved Therapy for Children with Early-onset Metachromatic Leukodystrophy
Wednesday 20 March 2024 (1 month ago) • GlobeNewswire Inc.

Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy for Eligible Children with Early-onset Metachromatic Leukodystrophy in the U.S.
Tuesday 19 March 2024 (2 months ago) • GlobeNewswire Inc.

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 15-12G - Securities registration termination [Section 12(g)]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

Orchard Therapeutics Announces First Patient Randomized in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Monday 5 February 2024 (3 months ago) • GlobeNewswire Inc.

Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium
Friday 2 February 2024 (3 months ago) • GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness
Wednesday 31 January 2024 (3 months ago) • Edgar (US Regulatory)

Orchard Therapeutics Announces Agreement with the Beneluxa Consortium Enabling Reimbursed Access to Libmeldy
Thursday 25 January 2024 (3 months ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 25 January 2024 (3 months ago) • Edgar (US Regulatory)

More Orchard Therapeutics PLC News Articles

Woodside Petroleum

Verizon Communications

Invesco QQQ Trust Series 1

S&P ASX 300 Metals and M...

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions